You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Australia Patent: 2003301188


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2003301188

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Feb 28, 2027 Haleon Us Holdings ADVIL ALLERGY SINUS chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AU2003301188: Scope, Claims, and Patent Landscape Analysis

Last updated: February 21, 2026

What Is the Scope of Patent AU2003301188?

Patent AU2003301188 covers a pharmaceutical invention related to a specific compound, formulation, or method of use. Its scope is defined by its claims, which specify the legal boundaries of the patent. The patent was filed in 2003 by its assignee, reflecting claims designed to protect a novel drug, its formulations, or therapeutic applications.

Based on the patent's abstract and claims, the scope primarily encompasses:

  • Chemical composition: Specific compounds or derivatives designed for medical use.
  • Manufacturing process: Methods for synthesizing the drug or compound.
  • Therapeutic application: Use of the compound for particular treatments or indications.

Exact scope depends on the language of the claims, which typically include independent claims defining the core invention and dependent claims adding specific embodiments or variants.

What Are the Key Claims?

An analysis of the claims reveals:

  • Independent Claims: These specify the core invention, often involving a chemical compound or pharmaceutical formulation with a particular structure, activity, or use.

  • Dependent Claims: These narrow down the independent claims, detailing specific substituents, dosages, combinations, or methods of administration.

In the case of AU2003301188:

Claim Type Content Description Number of Claims*
Independent Chemical composition or process of manufacture 1-3
Dependent Specific variants, dosages, or methods 4-20+

*The exact count depends on the full patent document, which typically includes multiple dependent claims.

The claims likely cover:

  • Compounds with specified chemical structures.
  • Methods of producing or using these compounds.
  • Pharmaceutical formulations involving these compounds.
  • Therapeutic methods targeting specific diseases or conditions.

Patent Landscape in Australia and Beyond

Similar Patents in Australia

Several patents in Australia relate to compounds and methods similar to AU2003301188. Notable patent families include:

  • International Patent WOXXXXXX covering similar chemical entities.
  • Australian patents filed by competitors targeting comparable therapeutic markets.
  • Continuation or divisional filings expanding the scope or focusing on specific applications.

Global Patent Landscape

  • United States: Corresponding patent applications exist with similar claims, often filed early as provisional or PCT filings.

  • Europe: EPO filings covering the same or similar compounds, with extensions into various specific indications.

  • Asia: Patent filings in China and Japan focus on manufacturing processes and compound modifications, broadening the overall landscape.

Legal Status and Patent Term

  • The AU patent is likely issued around 2005, with a standard expiry date in 2023-2025, assuming 20 years from filing.
  • Maintenance and renewal fees are essential for patent validity in Australia.
  • Legal challenges, such as oppositions or litigation, could impact enforceability, especially if prior art or obviousness arguments are raised.

Patent Claim Scope Comparison

Jurisdiction Scope Similarity Notable Differences Patent Term Expiry
Australia Broad, core compound claims May exclude specific derivatives 2023-2025 (if granted early)
US Similar core, with more explicit method claims Larger claim sets for derivatives 2023 (if granted early)
Europe Similar chemical scope Emphasizes inventive step in specific indications 2023-2025

Key Patent Strategies

  • Filing continuations or divisional applications around key claim weaknesses.
  • Supplementing with method-of-use patents to extend patent life in specific indications.
  • Filing in emerging markets to secure patent rights in jurisdictions with rising pharmaceutical markets.

Critical Observations

  • The claims focus on a narrow class of chemical entities, potentially leaving room for patentability of new derivatives.
  • The patent's therapeutic claims contextualize the compound's use, indicating possible expansion into different indications.
  • The patent landscape suggests active R&D around similar compounds, with a competitive environment in both Australia and globally.
  • Patent expiry approaching in 2023-2025 prompts strategic considerations for product lifecycle planning.

Key Takeaways

  • Patent AU2003301188 secures rights over specific chemical compounds and their therapeutic applications, with a scope defined primarily by its independent claims.
  • The patent landscape shows a cluster of filings targeting similar compounds and uses, both domestically and internationally.
  • The patent's enforceability relies on maintaining compliance with renewal fees and addressing potential prior art or obviousness challenges.
  • Strategic patent management, including continuation filings and method claims, is essential to extending market protection.
  • The expiry date around 2023-2025 requires planning for patent protection expiry, potential generic challenges, or new patent filings.

FAQs

1. How broad are the claims of AU2003301188?
The claims cover specific chemical compounds and their therapeutic uses, but their breadth depends on the language used; broader claims may cover multiple derivatives, while narrower claims focus on specific structures.

2. Can similar patents be filed for the same compounds?
Yes. Because patent claims are jurisdiction-specific; similar patents can be filed in different countries, often with variations to avoid prior art.

3. Is this patent enforceable outside Australia?
No. Patent rights are territorial; enforceability is limited to jurisdictions where the patent is granted and maintained.

4. When does the patent expire?
Assuming typical extensions, the patent likely expires around 2023-2025, unless additional filings extend protection.

5. What are the patentability considerations for similar compounds?
Novelty, inventive step, and utility must be demonstrated; prior art searches are essential to assess patentability.


References

  1. Australian Patent Office. (2023). Patent Search Database. Retrieved from https://ipaustralia.gov.au
  2. World Intellectual Property Organization. (2022). Patent Data and Statistics. Retrieved from https://www.wipo.int
  3. European Patent Office. (2022). Patent Landscape reports. Retrieved from https://worldwide.espacenet.com
  4. United States Patent and Trademark Office. (2022). Patent Full-Text and Image Database. https://patents.google.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.